CCNB1 and breast cancer: Breast cancer cells in which the Notch pathway has been targeted, either by an inhibitor of γ-secretase or by Notch-1 RNAi, downregulate cyclin B1 and suffer G2/M arrest (Rizzo et al, 2008).